These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Vigilance behavior in interaction of the serotonin-selective antidepressant zimelidine and parenterally administered ethanol].
    Author: Schaffler K, Arnold H, Hörmann E.
    Journal: Arzneimittelforschung; 1982; 32(8):845-52. PubMed ID: 6215927.
    Abstract:
    A randomized, placebo-controlled double-blind crossover study was carried out in 8 healthy male subjects to evaluate the interaction of (Z)-3-(4-bromphenyl)-N,N-dimethyl-3-(3-pyridyl)-allylamine-dihydrochloride-monohydrate (zimelidine, Normud) -- a new antidepressive drug -- and alcohol. New methodological approaches to the problem consisted in a parenteral application of ethanol and the introduction of the computer-assisted Oculodynamic Test -- a new multi-dimensional psychophysiological research instrument -- monitoring saccadic eye movements, choice-reaction parameters and cardiorespiratory parameters. Classical disimprovement of these parameters after ethanol infusion (equivalent to 1 mg % BEC) could be seen up to 5 h after administration. Alcohol effects were not potentiated by the selective serotonin-reuptake inhibitor zimelidine -- in contrary even a significant vigilance-stabilizing effect and improvement against placebo/ethanol values could be demonstrated for most of the vigilance-related parameters.
    [Abstract] [Full Text] [Related] [New Search]